Khaled Ezzedine

19.3k citations

326 papers · 10.1k indexed · 5 hit papers · h-index 53

Dermatology top 0.05%
- Skin Protection and Aging 60
- Dermatology and Skin Diseases 47
- Acne and Rosacea Treatments and Effects 20
Cell Biology top 0.05%
- melanin and skin pigmentation 143
Sensory Systems top 0.2%
- Olfactory and Sensory Function Studies 48
Immunology top 1%
- Atherosclerosis and Cardiovascular Diseases 39
- Mast cells and histamine 27
Nutrition and Dietetics top 0.2%
- Biochemical Analysis and Sensing Techniques 40

Co-authors: Alain Taı̈eb Christina Bergqvist Viktoria Eleftheriadou Nanja van Geel Maxine E Whitton Iltefat Hamzavi John E. Harris Amit G. Pandya
Cited by: Dermatology Cell Biology Sensory Systems
Journals: Journal of the European Academy of Dermatology and Venereology (37 papers)British Journal of Dermatology (37 papers)Journal of the American Academy of Dermatology (28 papers)
Partner nations: France United States Belgium

In The Last Decade

Khaled Ezzedine

306 papers receiving 9.9k citations

Hit Papers

5 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2022 New England Journal of Medicine
2020 Dermatology
2015 The Lancet
2012 Pigment Cell & Melanoma Research
2009 PEDIATRICS

Peers

Countries citing papers authored by Khaled Ezzedine

Since Specialization

Citations

This map shows the geographic impact of Khaled Ezzedine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Ezzedine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Ezzedine more than expected).

Fields of papers citing papers by Khaled Ezzedine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Ezzedine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Ezzedine. The network helps show where Khaled Ezzedine may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Khaled Ezzedine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Khaled Ezzedine Line = papers co-authored together Khaled Ezzedine links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo JAMA Dermatology ·Julien Sénéschal,Alison G. Sulloway,Nick Jarman,J. Mazereeuw‐Hautier,Naotaka Minami,Yueting Cao,Khaled Ezzedine,Thierry Passeron,Katia Boniface	2025	6
2	Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy Dermatology and Therapy ·Thomas P. Mackey,Thomas Bieber,Amy S. Paller,Lisa A. Beck,Masahiro Kamata,L. Puig,Marni Wiseman,Khaled Ezzedine,Alan D. Irvine,Peter Foley,J.Q. Del Rosso,Linda Stein Gold,Thais Lizondo López,Martín Dossenbach,Gaia Gallo,Jelte S. Woudsma,Marta Casillas,Marin Mlinarevic,金延萍,Raj Chovatiya	2025	7
3	The Impact of Atopic Dermatitis on Employment and Productivity: A French Study Acta Dermato Venereologica ·Khaled Ezzedine,Julien Sénéschal,Yunanda Eka Putra,Bruno Halioua,Francesca Sampogna,Stéphanie Mérhand,Charbel Skayem,Lidon Antonio,C. Taïeb,L. Misery,D. Staumont‐Sallé,M.‐A. Richard	2025	0
4	Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo Dermatology and Therapy ·David Rosmarin,Amit G. Pandya,Thierry Passeron,Seth Forman,Jacek Zdybski,Matthew Bogart,G. MacA. Dowson,Kim Papp,Anthony A. Nuara,Deanna Kornacki,Jean-Yves Vollmer,Haobo Ren,John E. Harris,Khaled Ezzedine	2025	0
5	Value of tacrolimus 0.1% in the treatment of vitiligo in the era of targeted therapy Annales de Dermatologie et de Vénéréologie ·Lang Jiying,杨志顺,Julien Sénéschal,Khaled Ezzedine,Jonathan Lacombe,Cemal Ağırman,Imoh Sunday OBOT,Bożena Dziemidok Olszewska,John J. Felicione,高瑞林 GAO Rui-lin	2025	0
6	Estimating the burden of vitiligo: a systematic review and modelling study The Lancet Public Health ·Ingrid Fries,Solam Lee,Hyun Jeong Ju,Rosa Parisi,信誠丹羽,Surakit Visuttiwattanakorn,Jimena V. Alvarez-Castanon,Viktoria Eleftheriadou,Iltefat Hamzavi,C.E.M. Griffiths,Darren M. Ashcroft,Venkataram Mysore,Somesh Gupta,Davinder Parsad,Henry W. Lim,Jung Min Bae,Khaled Ezzedine	2024	36
7	Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1 Journal of Investigative Dermatology ·L. Fertitta,徐海利,O. Zehou,Christina Bergqvist,S. Ferkal,Mahi Kolla,Lionel Lerman,Sebastien Mulé,Alain Luciani,Blanche Bapst,Khaled Ezzedine,Nicolás Ortonne,Emmanuel Itti,P. Wolkenstein	2024	3
8	722 - Efficacy of povorcitinib for the treatment of vitiligo by patient demographics and baseline clinical characteristics: week 52 subgroup analysis from a randomized, placebo-controlled, phase 2b clinical trial British Journal of Dermatology ·Amit G. Pandya,Thierry Passeron,Andrew Blauvelt,Nanja van Geel,Amal shaker Abood,Qiu Kun,Zhenyi Xue,Khaled Ezzedine	2024	0
9	Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses Experimental Dermatology ·Elena Peeva,Yuji Yamaguchi,Zhan Ye,直作内田,Mauro Picardo,Editors Marrane et marronne,Khaled Ezzedine,Ester Del Duca,Yeriel Estrada,Mina Hassan‐Zahraee,Wen He,Craig Hyde,Gerard Stinistra,Paola Facheris,Emma Guttman‐Yassky	2024	2
10	Assessing Participants’ Experiences with Vitiligo from Patient Interviews Dermatology and Therapy ·Amit G. Pandya,和英山口,Kristen Bibeau,Dana DiBenedetti,Katherine Kosa,Kathleen Butler,Deanna Kornacki,Khaled Ezzedine	2024	4
11	Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study EClinicalMedicine ·Thierry Passeron,Khaled Ezzedine,Iltefat Hamzavi,Nanja van Geel,Bethanee J. Schlosser,Xiaoqiang Wu,Xiaohong Huang,Ahmed M. Soliman,David Rosmarin,John E. Harris,Heidi S. Camp,Amit G. Pandya	2024	16
12	Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi study Journal of the American Academy of Dermatology ·MacDonald Wer,Michelle Rodrigues,Magyar Imre,Luis Rossler,Marwa Abdallah,Jung Min Bae,Marcel W. Bekkenk,Caio César Silva de Castro,Abebe Addisie,Samia Esmat,Khaled Ezzedine,Nanja van Geel,Iltefat Hamzavi,Giovanni Leone,Amit G. Pandya,Thierry Passeron,Noufal Raboobee,Julien Sénéschal,R Jena,Albert Wolkerstorfer	2023	1
13	43912 Facial Vitiligo Area Scoring Index Response Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies Journal of the American Academy of Dermatology ·John E. Harris,David Rosmarin,Julien Sénéschal,Amit G. Pandya,Mark Lebwohl,Khaled Ezzedine,Deanna Kornacki,Haobo Ren,Kathleen Butler,Thierry Passeron	2023	1
14	cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults Journal of Investigative Dermatology ·L. Fertitta,Kavita Y. Sarin,Christina Bergqvist,理香真崎,晳舘野,Mahi Kolla,Stella Feyisayo Adebayo,徐海利,S. Ferkal,Philippe Ravaud,Helen A. Northcutt,Jaishri O. Blakeley,Carlos G. Romo,Khaled Ezzedine,P. Wolkenstein	2023	2
15	Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice Trials ·Nanja van Geel,Iltefat Hamzavi,Amit G. Pandya,Albert Wolkerstorfer,Julien Sénéschal,Amit Garg,Phyllis I. Spuls,Caroline B. Terwee,Susan Mallett,Reinhart Speeckaert,B. Brandt,Viktoria Eleftheriadou,Khaled Ezzedine	2022	5
16	Which patients present to dermatologic emergencies? A survey on 1561 patients Journal of the European Academy of Dermatology and Venereology ·Charbel Skayem,水田大輝,L. Fardet,Khaled Ezzedine,Shimizu Hirofumi,S. Oro,P. Wolkenstein,O. Chosidow,T.A. Duong	2021	0
17	<p>Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis</p> Clinical Cosmetic and Investigational Dermatology ·Khaled Ezzedine,穂積米沢,Roberte Aubert,J.‐B. Monfort,Z. Reguiaï,Jason Shourick,C. Taïeb,F. Maccari	2020	3
18	A genome wide association study identifies new genes potentially associated with eyelid sagging Experimental Dermatology ·Vincent Laville,Sigrid Le Clerc,Khaled Ezzedine,年祈廖,Lieng Taing,Paul Rodriques,Cédric Coulonges,Damien Ulveling,Pilar Galán,Christiane Guinot,Léopold Fezeu,Frédérique Morizot,Julie Latreille,Denis Malvy,Erwin Tschachler,Jean‐François Zagury	2018	8
19	Lessons of a day hospital: Comprehensive assessment of patients with albinism in a European setting Pigment Cell & Melanoma Research ·Hugues Boisvert,Eulalie Lasseaux,Khaled Ezzedine,C. Léauté‐Labrèze,F. Boralévi,Julio K. Inafuco,Kelly Smith,Federico. Vicario,Benoı̂t Arveiler,Alain Taı̈eb,Fanny Morice‐Picard	2017	26
20	Propranolol for Severe Infantile Hemangiomas: Follow-Up Reportbreakdown → PEDIATRICS ·张华福,Eric Dumas de la Roque,Jérôme Berge,Nicolas Grenier,F. Boralévi,J. Mazereeuw‐Hautier,Dan Lipsker,J.M. Shyu,Khaled Ezzedine,P Vergnes,Alain Taı̈eb,C. Léauté‐Labrèze	2009	399

About Khaled Ezzedine

Khaled Ezzedine is a scholar working on Dermatology, Sensory Systems and Cell Biology, having authored 326 papers that have together received 10.1k indexed citations. Recurring topics across this work include melanin and skin pigmentation (143 papers), Skin Protection and Aging (60 papers), Olfactory and Sensory Function Studies (48 papers), Dermatology and Skin Diseases (47 papers), Biochemical Analysis and Sensing Techniques (40 papers), Atherosclerosis and Cardiovascular Diseases (39 papers), Mast cells and histamine (27 papers) and Acne and Rosacea Treatments and Effects (20 papers). The work is most often cited by research in Dermatology (3.0k citations), Cell Biology (5.4k citations) and Sensory Systems (1.3k citations). Khaled Ezzedine has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Alain Taı̈eb, Christina Bergqvist, Viktoria Eleftheriadou, Nanja van Geel, Maxine E Whitton, Iltefat Hamzavi, John E. Harris, Amit G. Pandya, Denis Malvy and C. Léauté‐Labrèze. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Journal of the American Academy of Dermatology, Acta Dermato Venereologica and Journal of Investigative Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact